Question marks over our ability to predict the future provided two of the highlights of our recent annual pensions conference. Senior Partner Nick Salter explores...
For a recent survey, Barnett Waddingham gathered information on Solvency II capital requirements for longevity from eight internal model firms and we found significant variations in assumptions.
Our recently released report on the state of play in the bulk annuity market, Barnett Waddingham’s Bulk Annuity Annual Report 2016, examines the latest developments in the market.
Scott Eason and Michael Henderson explore the potential implications of the PRA’s announcement to undertake a review of Equity Release Mortgages.
With the Solvency II implementation date looming, firms must make sure their processes are ready to meet the requirements. We explore how a standard formula Solvency Capital Requirement calculation tool can be made as simple as possible for the end user.
This blog post was written by Dave Grimshaw and Jon Palin who discussed and compared a range of methods for projecting future improvements in mortality at the IFoA’s Life Conference on 20 November. The session was aimed at delegates without specialist longevity expertise, who need to assess proposed assumptions.
Rewind to 1900 and infectious diseases were the second biggest cause of death in England and Wales. By 1960, deaths from infectious diseases were all but eradicated.
It is common knowledge that smoking is the primary catalyst for lung cancer, the second and sixth highest cause of death for males and females respectively in 2012 . However, male and female mortality has been affected differently by changing prevalence of smoking.
Smoking kills. No surprises there. It has also been recognised in the pricing of term insurance in the UK since the early 1980s and more recently in annuity pricing. But what do we know about the impact of smoking on mortality improvements?